Farshad Farzadfar

Measuring The Harms Caused by Illicit Drugs. A New Methodology for Estimating Drug Harm Index.

Novin MH, Razaghi E, Farzadfar F, Tarokh MJ, Rouhifard M.

Subst Use Misuse. 2024 Jul 28. 1-9. PMID: 39069745

Alcohol consumption among Iranian population based on the findings of STEPS survey 2021.

Hajebi A, Nasserinejad M, Rezaei N, Azadnajafabad S, Rashidi MM, Ahmadi N, Ghasemi E, Farzi Y, Yoosefi M, Djalalinia S, Fattahi N, Rezaei S, Foroutan Mehr E, Kazemi A, Haghshenas R, Rezaee K, Momen Nia Rankohi A, Afsari M, Mahdavihezaveh A, Jamshidi H, Farzadfar F.

Sci Rep. 2024 07 22. 14(1):16819. PMID: 39039151

Exposure assessment of metal(loids) in indoor air and biomonitoring in six urban residential areas in Iran.

Soleimani Z, Azimi P, Haghshenas R, Farzi Y, Taherkhani A, Naddafi K, Yunesian M, Naserinjad M, Behnoush AH, Parizad M, Keyvani M, Hajebi A, Gorgani F, Mirzaei S, Handy RD, Mesdaghinia A, Farzadfar F.

Sci Total Environ. 2024 Oct 10. 946:174169. PMID: 38917899

Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data.

Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, Rohloff P, Houehanou C, Norov B, Karki KB, Azangou-Khyavy M, Marcus ME, Aryal KK, Brant LCC, Theilmann M, Cífková R, Lunet N, Gurung MS, Mwangi JK, Martins J, Haghshenas R, Sturua L, Vollmer S, Bärnighausen T, Atun R, Sussman JB, Singh K, Moghaddam SS, Guwatudde D, Geldsetzer P, Manne-Goehler J, Huffman MD, Davies JI, Flood D.

Glob Heart. 2024. 19(1):44. PMID: 38708405

Correction: Global, regional, and national burden and quality of care index (QCI) of oral disorders: a systematic analysis of the global burden of disease study 1990-2017.

Shoaee S, Ghasemi E, Sofi-Mahmudi A, Shamsoddin E, Tovani-Palone MR, Roshani S, Heydari MH, Yoosefi M, Masinaei M, Azadnajafabad S, Mohammadi E, Rezaei N, Larijani B, Fakhrzadeh H, Farzadfar F.

BMC Oral Health. 2024 May 02. 24(1):512. PMID: 38698369

Infective Endocarditis in North Africa and the Middle East, 1990?2019: Updates from the Global Burden of Disease Study 2019.

Malakan Rad E, Momtazmanesh S, Saeedi Moghaddam S, Rezaei N, Rezaei N, Jamshidi H, Naghavi M, Larijani B, Farzadfar F.

Arch Iran Med. 2024 May 01. 27(5):229-238. PMID: 38690789

Unveiling the lead exposure attributed burden in Iran from 1990 to 2019 through the lens of the Global Burden of Disease study 2019.

Karimi H, Mahdavi S, Moghaddam SS, Abbasi-Kangevari M, Soleimani Z, Esfahani Z, Masinaei M, Fateh SM, Golestani A, Dilmaghani-Marand A, Kompani F, Rezaei N, Ghasemi E, Larijani B, Farzadfar F.

Sci Rep. 2024 04 15. 14(1):8688. PMID: 38622232

Trend and projection of non-communicable diseases risk factors in Iran from 2001 to 2030.

Farzadfar F, Yousefi M, Jafari-Khounigh A, Khorrami Z, Haghdoost A, Shadmani FK.

Sci Rep. 2024 04 06. 14(1):8092. PMID: 38582931

Exposure and biomonitoring of PAHs in indoor air at the urban residential area of Iran: Exposure levels and affecting factors.

Soleimani Z, Haghshenas R, Farzi Y, Taherkhani A, Naddafi K, Hajebi A, Behnoush AH, Khalaji A, Mirzaei S, Keyvani M, Saeify S, Kalantar R, Yunesian M, Mesdaghina A, Farzadfar F.

Chemosphere. 2024 May. 356:141886. PMID: 38582159

The synergistic effect of obesity and dyslipidemia on hypertension: results from the STEPS survey.

Mohseni P, Khalili D, Djalalinia S, Mohseni H, Farzadfar F, Shafiee A, Izadi N.

Diabetol Metab Syndr. 2024 Apr 03. 16(1):81. PMID: 38566160